{"name":"Takeshi Morimoto","slug":"takeshi-morimoto","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"12-month Edoxaban","genericName":"12-month Edoxaban","slug":"12-month-edoxaban","indication":"Other","status":"marketed"},{"name":"Goreisan","genericName":"Goreisan","slug":"goreisan","indication":"Other","status":"marketed"},{"name":"Long DOAC","genericName":"Long DOAC","slug":"long-doac","indication":"Other","status":"marketed"},{"name":"No Carvedilol","genericName":"No Carvedilol","slug":"no-carvedilol","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"12-month Edoxaban","genericName":"12-month Edoxaban","slug":"12-month-edoxaban","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Goreisan","genericName":"Goreisan","slug":"goreisan","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Long DOAC","genericName":"Long DOAC","slug":"long-doac","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"No Carvedilol","genericName":"No Carvedilol","slug":"no-carvedilol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBqWElSVzNmUF9OLUxZQTBYanRnZDEwZlJySmp3OTYzRUJkdWREZ3VuVVQ2S2I1WFNiUmx3MUR6QUhFYnJrWEtnaXZwNjJBNE1aR1hfamdEX2l5Z1NacHdr?oc=5","date":"2020-06-25","type":"trial","source":"nature.com","summary":"Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glaucoma patients: ROCK-S, a multicentre historical cohort study - nature.com","headline":"Intraocular pressure-lowering effects of ripasudil in uveitic glaucoma, exfoliation glaucoma, and steroid-induced glauco","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}